Search by Journal
- HOME
- > Search by Journal
- > Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface
Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface
Volume , Issue suppl / 2025
English Article
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
|
Japanese pulmonary surfactant, interface medical society 61st arts and sciences workshop's chairperson greetings 鈴木拓児 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 1-1, 2025. |
|---|
|
|
To the 21st century "life magazine medicine" development: Breathing, rebound (search of two bundles of straw sandals) to solve in Molecular Biology 貫和敏博 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 10-10, 2025. |
|---|
|
|
Identification of the proliferative high stem cell subset contributing to the anagenesis of the lungs 森本充 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 11-11, 2025. |
|---|
|
|
Inflammation that the lungs store: Why does inflammation become chronic? 平原潔 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 12-12, 2025. |
|---|
|
|
Problem - RPH study first report - to the disease course and treatment optimization after the GM-CSF inhalation therapy in the autoimmune alveolar proteinosis 吉田知栄子1), 中田光2), 坂上拓郎3) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 13-13, 2025. |
|---|
|
|
We think about optimization of the GM-CSF inhalation therapy for autoimmune alveolar proteinosis (aPAP). 大河内眞也1)2) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 14-14, 2025. |
|---|
|
|
The effect that basics and Amikacin liposomal inhalation suspension of pulmonary nontuberculous acid-fast bacterium disease treatment give to the lungs 若林宏樹 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 15-15, 2025. |
|---|
|
|
SP-A and trace ... to SP-D - measurement kit development and serologic diagnosis 黒木由夫 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 16-16, 2025. |
|---|
|
|
An impact and the problem that we resulted in for SP-A and SP-D - ILD diagnosis, management 高橋弘毅 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 17-17, 2025. |
|---|
|
|
01. Clinical characteristic examination about the serum SP-D level in patients with drug-related pulmonary disorder with the lung cancer medical therapy and the serum KL-6 level 高橋知之, 齋藤充史, 千葉弘文 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 18-18, 2025. |
|---|
|
|
02. Analysis of SFTPD variant and the clinical course in the fibrous hypersensitivity pneumonitis 安部豪眞1), 岡本師1), 園田史朗1), 石塚聖洋1), 白井剛1), 古澤春彦1), 立石知也1), 岩見卓朗1), 寺尾知可史3), 高地雄太2), 宮崎泰成1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 19-19, 2025. |
|---|
|
|
03. Develop-ment research of the macrophage control medicine which paid its attention to new target molecule FROUNT (the front desk) for intractable respiratory illness 寺島裕也, 松島綱治 Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 20-20, 2025. |
|---|
|
|
04. A case of the autoimmune alveolar proteinosis merger fiber-related hypersensitivity pneumonitis: Pathologic consideration by the change over time of antiGM-CSF autoantibody concentrations 新井徹1), 広瀬雅樹1), 初田和由1), 井上義一1)2), 澄川裕允3), 武村民子4), 清水重喜5) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 21-21, 2025. |
|---|
|
|
05. The condition of a patient analysis about fibrosis of the autoimmune alveolar proteinosis judging from peripheral-blood mononuclear cells function 平間隆太郎1), 川崎剛1), 村井優志1), 佐久間典子1)2), 佐藤峻1), 鈴木拓児1) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 22-22, 2025. |
|---|
|
|
06. Study on formation mechanism of the amorphia sediment of the alveolar proteinosis 中田光1), 赤坂圭一2), 山縣彰3), 大房健3), 早津学4) Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface (suppl): 23-23, 2025. |
|---|
